Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome.
A female infant with DiGeorge syndrome associated with severe T-cell immunodeficiency underwent a successful bone marrow transplantation from her HLA-identical, mixed leukocyte culture-nonreactive brother at 5 months of age. Mature circulating T cells and mitogen-induced proliferative responses were detectable at 10 days posttransplant, and by 8 months post-transplant functional T- and B-cell reconstitution was documented by normal responses to mitogens and normal levels of serum immunoglobulins as well as in vitro and in vivo T-cell reactivity to specific antigens and production of specific antibody to T cell-dependent antigens in vivo. Phytohemagglutinin-induced interleukin-2 production and cell surface interleukin-2 receptor expression improved posttransplant, with normal production values observed by 8 months posttransplant. Histologic examination of appendix and thoracic lymph node obtained 9 and 17 months posttransplant, respectively, revealed near-normal lymphoid architecture, with germinal center formation providing morphologic confirmation of reconstitution. Stable split lymphoid chimerism with T cells of donor origin and B cells remaining recipient in origin was documented by sex chromosome analysis. Two years posttransplant the subject remains free of serious infections. In conclusion, this case indicates that bone marrow transplantation can produce peripheral immunoreconstitution without need for significant thymic influence, most likely by providing a source of postthymic T cells, and that bone marrow transplantation should be considered a therapeutic option in patients with DiGeorge syndrome associated with severe T-cell deficiency.
Borzy
M S
MS
Department of Pediatrics, School of Medicine, Oregon Health Sciences University, Portland 97201.
Ridgway
D
D
Noya
F J
FJ
Shearer
W T
WT
D016026:Bone Marrow Transplantation / Q000276:immunology*; D002469:Cell Separation; D002678:Chimera / Q000276:immunology*; D004062:DiGeorge Syndrome / Q000276:immunology / Q000601:surgery*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000601:surgery*; D007231:Infant, Newborn; D007376:Interleukin-2 / Q000096:biosynthesis; D008214:Lymphocytes / Q000276:immunology* / Q000648:ultrastructure; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis; D012730:Sex Chromosomes
D007136:Immunoglobulins; D007376:Interleukin-2; D015375:Receptors, Interleukin-2